---
figid: PMC6589502__fig-3
figlink: /pmc/articles/PMC6589502/figure/f3/
number: <b>Figure 3.</b>
caption: Schematic diagram summarizing the possible pathway of key elements in GSD.
  In this schema, immunological responses, related secreted cytokines, and cells are
  shown. The arrows indicate the activated directions and lateral lines indicate suppressive
  actions. The development of lesions in GSD has been associated with angiogenic and
  lymphangiogenic factors. The formation of bone lymphatics and osteoclast-mediated
  bone resorption can be seen in affected bone lesions of GSD patients. The endothelial
  cells in GSD patients highly express CD105 and activate osteal macrophages by producing
  IL-1. VEGF and TGF-β produced by osteal macrophages promote angiogenesis and lymphangiomatosis.
  CTX-1, C-terminal telopeptide of type I collagen; GSD, Gorham–Stout disease; IFN,
  interferon; IL, interleukin; OPG, osteoprotegerin; PGE2, prostaglandin E2; RANK,
  receptor activator of nuclear factor κB; RANKL, ligand for receptor activator of
  nuclear factor κB; TGF, transforming growth factor; Th, helper T; TNF, tumor necrosis
  factor.
pmcid: PMC6589502
papertitle: 'Generalized Lymphatic Anomaly and Gorham–Stout Disease: Overview and
  Recent Insights.'
reftext: Michio Ozeki, et al. Adv Wound Care (New Rochelle). 2019 Jun 1;8(6):230-245.
pmc_ranked_result_index: '122028'
pathway_score: 0.9737688
filename: fig-3.jpg
figtitle: 'Generalized Lymphatic Anomaly and Gorham–Stout Disease: Overview and Recent
  Insights'
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6589502__fig-3.html
  '@type': Dataset
  description: Schematic diagram summarizing the possible pathway of key elements
    in GSD. In this schema, immunological responses, related secreted cytokines, and
    cells are shown. The arrows indicate the activated directions and lateral lines
    indicate suppressive actions. The development of lesions in GSD has been associated
    with angiogenic and lymphangiogenic factors. The formation of bone lymphatics
    and osteoclast-mediated bone resorption can be seen in affected bone lesions of
    GSD patients. The endothelial cells in GSD patients highly express CD105 and activate
    osteal macrophages by producing IL-1. VEGF and TGF-β produced by osteal macrophages
    promote angiogenesis and lymphangiomatosis. CTX-1, C-terminal telopeptide of type
    I collagen; GSD, Gorham–Stout disease; IFN, interferon; IL, interleukin; OPG,
    osteoprotegerin; PGE2, prostaglandin E2; RANK, receptor activator of nuclear factor
    κB; RANKL, ligand for receptor activator of nuclear factor κB; TGF, transforming
    growth factor; Th, helper T; TNF, tumor necrosis factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - ENG
  - IL1A
  - IL6
  - TNFRSF11B
  - TNFRSF11A
  - VEGFC
  - TNFSF11
  - TGFB1
  - TGFB2
  - TGFB3
  - TNF
  - IL10
  - IL12B
  - IL17A
  - PGF
  - VEGFA
  - VEGFB
  - IL12A
  - VEGFD
genes:
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: CD105
  symbol: CD105
  source: hgnc_alias_symbol
  hgnc_symbol: ENG
  entrez: '2022'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: OPG
  symbol: OPG
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF11B
  entrez: '4982'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF-C↑
  symbol: VEGFC
  source: hgnc_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: RANKL
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL-17
  symbol: IL-17
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
chemicals: []
diseases: []
---
